Neotegogjeong 50 mg (Tegoprazan)

Adult dose

This medicine is administered to adults as follows. 1. Treatment of erosive gastroesophageal reflux disease Administer 50 mg orally once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, administer for an additional 4 weeks. 2. Treatment of non-erosive gastroesophageal reflux disease Administer 50 mg orally once daily for 4 weeks. 3. Treatment of gastric ulcers Administer 50 mg orally once daily for 8 weeks. 4. Concomitant antibiotic therapy for Helicobacter pylori eradication in patients with peptic ulcers and/or chronic atrophic gastritis Patients with Helicobacter pylori infection should receive eradication therapy. Administer this medicine 50 mg with amoxicillin 1 g and clarithromycin 500 mg orally twice daily for 7 days. 5. Maintenance treatment after treatment of erosive gastroesophageal reflux disease <limited to 25mg> Administer 25 mg orally once daily. This medicine may be taken with or without food.

This medication should not be administered to specific patients. Patients who are allergic to this drug or its ingredients or have a history of hypersensitivity, patients taking specific antiviral drugs, and women who are pregnant or breastfeeding should not use this medication. Patients with liver or kidney impairment, as well as the elderly, should use this medication with caution. This is because safety and efficacy in patients with liver or kidney disorders have not been adequately established. While taking this medication, various adverse reactions may occur. Common symptoms include nausea, diarrhea, indigestion, headache, and dizziness, while rare cases of skin rash or liver function abnormalities have also been reported. Long-term use of this medication may result in vitamin B12 deficiency, so regular monitoring is necessary. Additionally, due to the inhibition of gastric acid secretion, the risk of bacterial infection in the gastrointestinal tract may increase, so if diarrhea persists, medical consultation is advisable. This medication suppresses gastric acid secretion, and therefore may interact with other medications. Particular caution is warranted when taken with specific antiviral drugs, antifungal agents, or iron preparations, as the effects may decrease or increase. Pregnant or breastfeeding women should not take this medication, and those planning to become pregnant should consult with a healthcare provider. The safety and efficacy of this medication have not been sufficiently established in children and adolescents, so its use is not recommended. Elderly individuals should exercise caution due to the potential for liver and kidney function decline. No specific symptoms of overdose have been reported; however, if symptoms occur, immediate medical attention should be sought for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to other containers as it is important for maintaining its quality.

• Nausea
• diarrhea
• indigestion
• pharyngitis
• viral upper respiratory infection
• chest discomfort
• upper abdominal pain
• abdominal discomfort
• constipation
• abdominal pain

This medication must be stored in a tightly sealed container to protect it from air or moisture. Additionally, it is advisable to store the medication at room temperature, ideally between 1 and 30 degrees Celsius, avoiding extremes of heat or cold.

Appearance

Pale pink oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle